Genetics 4 - Cancer Flashcards

1
Q

What are the hallmarks of cancer?

A
  • Disregulated growth
  • Evasion of apoptosis
  • Limitless replication
  • Metastisis
  • IMPORTANT: genome instability and mutation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Why is cancer a polyclonal disease?

A

Cumulative changes result in cancer, meaning that there are many different cells with different mutations in one tumour.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are driver mutations in cancer?

A

An initial mutation that occurs in either oncogenes or tumour supressor genes. This first hit is usually a point mutation which cant produce a phenotypic effect.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Summarise the two hit hypothesis.

A

Hit 1 is a point mutation, which reduces protein level but doesnt cause phenotypic effect. Therefore, inactivation of a second allele is required - this is hit 2, causes total loss of transcription.
This is required in tumour suppressor genes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the function of proto-oncogenes? Give some examples.

A

They promote growth and proliferation, overriding apoptosis:

  • Growth factors
  • Transcription factors
  • Tyrosine kinases
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the function of tumour suppressors?

A

These regulate cell division at the DNA damage checkpoints. They can cause apoptosis and DNA repair.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How can cancers be identified in the genetics?

A

They can be identified by a loss of heterogenity due to mutations.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the difference between familial retinoblastoma and a sporadic retinoblastoma?

A

Familial - first hit is inherited, second hit is a somatic mutation
Sporadic - two somatic mutations occur in the same cell (hit 1 & hit 2)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What inherited mutation is linked to breast and ovarian cancer?

A

Germline mutations in BRCA1 and BRCA2, DNA repair genes. They give rise to a 60% risk of cancer by age 90. BRCA2 mutations also predispose risk of breast cancer in men.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What two diseases result in an inherited predisposition to colorectal cancer?

A
  • Familial adenomatous polyposis (FAP)

- Lynch syndrome (HNPCC)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the colorectal cancer risks in patients with familial adenomatous polyposis?

A

Almost a 100% lifetime risk of cancer.

Responsible for >1% of colorectal cancers.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the risk of colorectal cancer in patients with lynch syndrome?

A

Responsible for 3% of cancer cases, and 90% of familial cases.
The lifetime risk for cancer is around 80%.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How are patients treated if a inherited cancer syndrome is detected?

A
  • If a patient has positive family history then they will recieve genetic screening/counseling.
  • If they are mutation positive then they recieve surveillance, chemoprevention and family work-up
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How may the causes of polygenic cancer be studied?

A
  • Using genome wide association studies to look for SNPs.
  • Using transcriptome chips/mRNA arrays to identify differently expressed transcripts (compares expression between malignant and normal tissue)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are cytogenetic changes in cancer?

A

These are visible changes in chromosome structure or number, which accumulate during disease progression. (Eg. Fusion genes, macroduplications or macrodeletions, aneuploidy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the cause of chronic myeloid leukaemias?

A

It is a clonal myeloproliferative disorder, where there is an overproduction of mature granulocytes.

17
Q

What are the three phases of chronic myeloid leukaemia?

A

Chronic (beningn), accelerated (ominous) and then blast crisis (acute leukaemic, fatal)

18
Q

What is the philadelphia chromosome?

A

A fusion protein which acts as the marker for CML. This allows CML to be treated by blocking the ATP binding site of the protein (BCR-ABL1)

19
Q

What are the two lines of treatment of CML and why are they needed?

A

First line is imantib, and eventually patients lose their response and require second line tyrosine kinase inhibitors.

20
Q

How is acute myeloid leukaemia divided?

A

Into FAB M0 to FAB M7.

  • FAB M3 is a medical emergency
  • FAB M5 is not
21
Q

What is pharmacogenetics?

A

A branch of pharmacology which deals with the influence of genetic variation in drug response.

22
Q

How can pharmacogenetics be used in cancer?

A
  • To plan chemotherapy
  • To identify which patients are likely to respond to certain cancer drugs
  • To assay particular somatic mutations
23
Q

How many mutations are required in oncogenes to cause cancer?

A

Only one gain of function mutation.

24
Q

How many mutatiosn are required in tumour suppressor genes to cause cancer?

A

Two mutations causing loss of function.

25
Q

How are chromosome translocations used to quantify residual disease in leukaemia?

A
  • The response to treatment over the first 3-12 months defines long term response to tyrosine kinase inibitors, which guides clonical management.
  • Absense of a cytogenetic response by 12 months results in change of therapy
  • Loss of RT-qPCR negativity is a indicator is relapse results in change of therapy.